Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
82 studies found for:    "Rubella"
Show Display Options
Rank Status Study
21 Completed
Has Results
Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMRV (AMP);   Biological: MMRV (2006 process)
22 Completed Coadministration of Measles-rubella and Rotavirus Vaccines
Conditions: Measles Antibody Seroconversion;   Rubella Antibody Seroconversion;   Rotavirus GMT;   Rotavirus IgA Seropositivity
Interventions: Biological: Rotarix vaccine;   Biological: measles-rubella vaccine
23 Completed Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination
Condition: Measles/Rubella
Intervention: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain)
24 Completed Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination
Condition: Measles/Rubella
Intervention: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain)
25 Completed Making Decisions About the Measles-Mumps-Rubella Vaccine
Conditions: Measles;   Mumps;   Rubella;   MMR Vaccination
Intervention: Other: Behavioral: Computer-based tailoring system
26 Completed Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM
Conditions: Varicella;   Rubella;   Mumps;   Measles
Interventions: Biological: GSK Biological's investigational MMRV vaccine 208136;   Biological: Priorix™;   Biological: Varilrix™
27 Completed Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine
Conditions: Rubella;   Varicella;   Mumps;   Measles
Interventions: Biological: MMRV;   Biological: MMR (Priorix®);   Biological: Varicella (Varilrix®)
28 Completed Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine
Conditions: Measles;   Mumps;   Rubella;   Hepatitis A
Interventions: Biological: Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella;   Biological: Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine
29 Completed Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.
Conditions: Rubella;   Mumps;   Measles
Intervention: Biological: MMR vaccine (Priorix)
30 Terminated
Has Results
A Study of ProQuad™ in Healthy Children in Korea (V221-023)
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™);   Biological: M-M-R™ II and Varivax™
31 Active, not recruiting Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR
Conditions: Measles;   Rubella;   Mumps
Intervention: Biological: Combined measles-mumps-rubella (MMR) vaccine - PRIORIX®
32 Completed Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly
Conditions: Varicella;   Measles;   Mumps;   Rubella;   Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B;   Haemophilus Infections
Intervention: Biological: ProQuad® and Infanrix® hexa
33 Completed Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix®) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M M R®II), in Children 12 to 15 Months of Age
Conditions: Rubella;   Measles;   Mumps
Interventions: Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209762);   Biological: Merck & Co., Inc.'s M-M-R®II (also called M-M-R Vax Pro®), combined measles-mumps-rubella virus vaccine;   Biological: Varivax® (Merck & Co., Inc.);   Biological: Havrix®;   Biological: Prevnar 13® (Pfizer Inc.)
34 Terminated Immune Responses to Two Dose Varivax +/- MMR-II
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMR-II;   Biological: Pro-Quad;   Biological: Varivax
35 Completed ProQuad® rHA Safety
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: ProQuad® manufactured with rHA
36 Completed Measles, Mumps, and Rubella (MMR) Immunity in College Students
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR vaccine
37 Terminated Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention:
38 Completed
Has Results
Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study
Conditions: Hepatitis A;   Measles;   Mumps;   Rubella;   Chickenpox
Interventions: Biological: VAQTA®;   Biological: ProQuad
39 Completed Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: MeMuRu-OKA (study vaccine)
40 Completed
Has Results
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
Conditions: Measles-Mumps-Rubella-Varicella Vaccine;   Diseases Caused by Measles, Mumps, Rubella and Varicella Viruses.
Interventions: Biological: Priorix-Tetra™ (MMRV vaccine 208136);   Biological: ProQuad®;   Biological: Havrix®;   Biological: Prevnar®

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years